Immunogenicity of a novel, bivalent, plant-based oral vaccine against hepatitis B and human immunodeficiency viruses

Biotechnol Lett. 2006 Jul;28(13):959-67. doi: 10.1007/s10529-006-9028-4. Epub 2006 Jun 23.

Abstract

A synthetic chimeric gene, TBI-HBS, encoding the immunogenic ENV and GAG epitopes of human immunodeficiency virus (HIV-1) and the surface protein antigen (HBsAg) of hepatitis B virus (HBV), was expressed in tomato plants. Tomato fruits containing the TBI-HBS antigen were fed to experimental mice and, on days 14 and 28 post-feeding, high levels of HIV- and HBV-specific antibodies were present in the serum and feces of the test animals. Intraperitoneal injection of a DNA vaccine directing synthesis of the same TBI-HBsAg antigen boosted the antibody response to HIV in the blood serum; however, it had no effect on the high level of antibodies produced to HBV.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Oral
  • Hepatitis B Vaccines / administration & dosage*
  • Hepatitis B Vaccines / genetics
  • Hepatitis B Vaccines / metabolism*
  • Hepatitis B virus / drug effects*
  • Hepatitis B virus / physiology
  • Plant Extracts / administration & dosage*
  • Plant Extracts / immunology*
  • Plants, Genetically Modified
  • Protein Engineering / methods
  • Solanum lycopersicum / genetics
  • Solanum lycopersicum / metabolism*

Substances

  • Hepatitis B Vaccines
  • Plant Extracts